Category: CannabisNewsWire Release

420 with CNW — Four Marijuana Products That May Offer Relief from PMS Symptoms

Periods usually affect women differently. While some feel discomfort, a huge number experience rough periods, enduring debilitating pain as well as symptoms such as abdominal pressure, muscle aches, nausea and more.

Premenstrual syndrome (“PMS”) is a group of symptoms that occur between ovulation and periods. It manifests in various symptoms and signs, which include irritability, fatigue, food cravings, tender breasts, mood swings and depression.

Research has shown that marijuana possesses medicinal benefits that are effective in the management of pain. Did you know, however, that it can also be used to obtain relief from premenstrual syndrome? The marijuana industry has maximized on this, developing different products, such as marijuana tampons and suppositories, designed to offer fast and localized relief in the treatment of some of these symptoms.

Below are some products that can help ease the discomfort caused by premenstrual syndrome.

Skin Creams and Balms

There exists in the market a variety of creams that can be applied on the lower abdomen and back, which are areas commonly affected by period pains. These products offer effective pain relief, with brands such as Well Care Botanicals producing some of the popular products in the market.

Marijuana balms can also be used on different parts of the body, offering analgesic effects for pain relief.

Suppositories

Marijuana suppositories have been developed to offer rapid pain relief. They take roughly 15 minutes to begin working and normally work on an individual’s pelvis region, helping relax the uterus and muscles.

Suppositories have varying levels of THC, depending on the brand. CBD suppository options also exist. Suppositories can also treat hemorrhoids and constipation, as well as make sexual intercourse less painful.

CBD Tinctures

Tinctures are strong and concentrated. CBD tinctures can heal premenstrual pain with just a few drops placed under an individual’s tongue. They act fast, kicking in within 10 minutes. Tinctures are said to be a safe option for daytime consumption because they do not induce highs.

However, tinctures typically have an oily and powerful taste, so keep that in mind when selecting pain-relief options.

Bath Salts

It is said that relaxation is a good remedy for many things, including period cramps and premenstrual pain, which means that cannabis bath salts and a long and relaxing bath may provide pain relief.

Cannabis bath salts are a powerful and effective way to offer relief from pain, lasting more than four hours.

A variety of brands can be found on the market, including products made by leading companies such as Simply Sonoma Inc., so there are plenty of options available.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – American Cannabis Partners Leverages Business Model Designed to Ensure Quality, Diversity of End Product

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, has centered its business model around three key pillars: the acquisition of prime, arable agricultural land; the development of proprietary assets; and ongoing cultivation operations. ACP now operates over 540,000 square feet of licensed canopy space for cultivation spread across the states of California and Michigan, with the company possessing the second-largest growing license within the latter state. A recent article reads, “American Cannabis Partners has designed its business model to help ensure the quality and diversity of its organic end product, a step which should assist in boosting the company’s profile and competitiveness in the event of a fully legalized U.S. market. Moreover, the company has sought to align traditional Jamaican cultivation techniques within its cannabis cultivation, harvesting and curing process, methods which have resulted in a superior product, faster growth rates, greater production yields, higher THC levels, and enhanced terpene bouquets. The level of exacting detail and care paid to its plants, as well as ACP’s adherence to sustainable Jamaican production practices, have led the company to produce some of the most sought-after flowers in the United States.”

To view the full article, visit https://cnw.fm/HMGrR

About American Cannabis Partners

American Cannabis Partners is a fully licensed, large scale and 100% organic cannabis cultivation company nationally headquartered in Trinity County of the Emerald Triangle. Guided by business professionals and cultivators, the company focuses on four industry segments: real estate, cultivation, medical research, and nonprofit groups. For both medical and recreational, American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Completes Strategic Acquisition, Expands Footprint in Country’s Largest Cannabis Market

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced that it has recently completed the acquisition of VBF Brands Inc. A Salinas, California-based marijuana cultivator and distributor, VBF was previously a wholly-owned subsidiary of Sunset Island Group Inc. (OTC: SIGO). MCOA expects that, based on activity since the acquisition was consummated in Q3 2021, the transaction will continue to be highly accretive to the company’s EBITDA expectations for 2022 and will work towards increasing production at a nearby Salinas-based facility that also offers exponential growth opportunities with other nearby land and facilities. California is the country’s largest legal cannabis market and offers tremendous potential for MCOA with this acquisition that includes cannabis nursery, manufacturing/distribution and cultivation licenses. “The acquisition of VBF Brands Inc. perfectly encapsulates MCOA’s strategy to expand our business by organic growth and acquisitions of synergistic and often undercapitalized assets existing today in the cannabis industry,” said Jesus Quintero, CEO of Marijuana Company of America. “We are confident that providing this entity with capital and operational depth to the already impressive operations will increase the capacity and greatly bolster our position in the California cannabis market.”

To view the full press release, visit https://cnw.fm/nViOb

About Marijuana Company of America Inc.

Marijuana Company of America operates and invests in the cannabis sector directly. The company’s operations include C-Distro, one of the fastest growing distribution companies in the THC, Hemp and CBD cannabis industries, and hempsmart(TM), a premium CBD company. The company’s core mission is to leverage its experience and access to capital to identify and invest in acquisitions with unique growth potential. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA 

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — VA Researcher Shares Cannabis Insights, Study Results during Latest Podcast

In a new podcast, a researcher from the Department of Veterans’ Affairs stated that individuals suffering from PTSD who use cannabis experience fewer symptoms of the disorder and recover more quickly than individuals who don’t. The forensic neuro-psychiatrist, Hal Wortzel, discussed the findings of an observational study he’d carried out during the podcast. This is in addition to talking about how the ongoing federal prohibition on cannabis has hindered research from progressing.

To learn how marijuana affects post-traumatic stress disorder, the team of researchers, led by Wortzel, tracked two groups comprising of 150 individuals living with the condition. Of this number, one-half used cannabis to manage their symptoms while the other half didn’t. The individuals were tracked for a period of years, with researchers noting that despite the limits to observational studies, their results offered evidence that cannabis has therapeutic benefits for some populations.

Wortzel stated that in comparison with those who didn’t use cannabis, those who used cannabis recovered more quickly and were roughly twice as likely to not meet the criteria for PTSD after a while. The research also found that cannabis wasn’t linked to better sleep or other functional activity levels and outcomes. This is surprising, as anecdotal evidence from many individuals report improved sleep with marijuana.

In the podcast, which is produced by the Rocky Mountain Mental Illness Research Education and Clinical Center, Wortzel stated that a greater investment in experimental studies on cannabis’ health impacts needed to be made. He explained that because cannabis and cannabis products were still federally illegal, researchers needed to use the products developed by the U.S. government to conduct experimental studies, which aren’t the products that the majority of people in the U.S. use or purchase from dispensaries.

Most researchers, including the head of NIDA, have complained that they are currently forced to use marijuana grown from one federally authorized source at the University of Mississippi to conduct studies; that marijuana isn’t available in the state-legal commercial markets.

This is one of the cannabis research barriers highlighted in a report that the National Institute of Drug Abuse submitted to Congress recently. Congressional legislators are currently focused on advancing measures to end cannabis prohibition.

However, officials from the Department of Veterans’ Affairs have rejected even the fairest legislation that was drafted to promote clinical research into the medical value of marijuana, as well as promote veteran access to medical cannabis. Such reluctance on the part of the VA may make it harder for veterans to access even the beneficial products currently available from companies such as Flora Growth Corp. (NASDAQ: FLGC).

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Bill to Remove Regulatory Grey Area for CBD in Drinks, Supplements Filed in Congress

Although CBD has been legal since the 2018 farm bill legalized the cultivation and growth of industrial hemp and its derivatives, the young industry is largely unregulated. Hemp stakeholders have urged the federal government to craft comprehensive regulations for CBD as sales of CBD-infused products ramp up, but the responsible agencies have dragged their feet. As a result, the cannabidiol industry has attracted plenty of dishonest entities that have flooded the market with subpar CBD products which can even put consumers’ health at risk.

After years of back and forth, a bill that would remove the regulatory gray area for CBD-infused supplements and drinks has finally been unveiled. Introduced by bipartisan House lawmakers, the CBD Product Safety and Standardization Act would compel the U.S. Food and Drug Administration (“FDA”) to develop regulations for the lucrative CBD market.

The FDA will also have to hold a public comment period for information gathering on the maximum amount of cannabidiol that can be added to a beverage or food item per serving. The public comment period will also be instrumental in helping the FDA determine proper packaging and labeling requirements as well as the ‘conditions of intended use,’ which refers to what the label claims a product is to be used for.

The bill is sponsored by Representatives Kathleen Rice, Morgan Griffith, Dan Crenshaw and Angie Craig. According to a press release from Rice, CBD’s popularity has increased exponentially in the recent past, but the industry has been held back by the absence of federal regulations. The murky regulatory landscape puts customers at risk by providing minimal protections against subpar and often contaminated products and leaves businesses clamoring for some clarity. The new bill will create a comprehensive regulatory framework that will ensure unsafe products stay off the shelves and provide cannabis businesses with the stability they need to succeed, Rice says.

Griffith says that the FDA still hasn’t caught up with the reality that CBD is massively popular and isn’t going anywhere anytime soon. Like Rice, he says that the lack of regulation has put consumer health at significant risk and filled cannabis businesses with uncertainty. The CBD Product Safety and Standardization Act would fix these issues by compelling the FDA to act on CBD swiftly. As expected, the new bill has been met with support from the U.S. Hemp Roundtable and Consumer Brands Association. Jonathan Miller, general counsel for the roundtable praised certain aspects of the bill and said the hemp industry is thankful to its sponsors.

A law regulating the use of cannabidiol in drinks and supplements would be of great help to sector players such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) since it would be clear what rules everyone in the industry is playing by.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Performance Reflects Ability to Execute on Diversification Strategy

Marijuana Company of America (OTC: MCOA) is a diversified holding company that is looking to grow its business and further establish itself in the legalized cannabis THC, hemp and cannabidiol (“CBD”) industries. MCOA recently achieved the highest quarterly revenue in its history and expects to drive continued growth across the entire business. “As part of the financial results for three months ended Sept. 30, 2021 (‘Q3 2021’), the company reported $442,178 in revenue, up from $53,195 in revenue reported in Q3 2020. This represented a 731% year-on-year increase. In addition, the company’s gross profits grew by 297%, from $16,025 reported in Q3 2020 to $63,687 in the most recent quarter,” reads a recent article, which quotes MCOA CEO Jesus Quintero on the company’s strong performance. “During the third quarter 2021, despite the fact that we have been in the midst of a global pandemic, the company produced the highest revenues in its history,” said Quintero. “Our Q3 financial performance was strong and reflects our ability, despite being in a challenging environment, to execute on the strategy by diversifying within the Cannabis industry through strategic acquisitions along with organic growth.”

To view the full article, visit https://cnw.fm/4vKrW

About Marijuana Company of America Inc.

Marijuana Company of America operates and invests in the cannabis sector directly. The company’s operations include C-Distro, one of the fastest growing distribution companies in the THC, Hemp and CBD cannabis industries, hempsmart(TM), a premium CBD company, and a Salinas, California-based cannabis nursery cultivation facility that is a cultivator and distributor utilizing its own growing systems to produce desirable cannabis clones. The company’s core mission is to leverage its experience and access to capital to identify and invest in acquisitions with unique growth potential. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Continues Building ‘Full Farm-to-Sale Vertical Model’

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, recently announced the grand opening of its first Los Angeles-based, customer-facing MDRN (Modern) Tree cannabis dispensary. A recent article quotes NUGS CEO Simon Yu on the move, who stated, “We continue to build a full farm-to-sale vertical model, and MDRN Tree is a big part of that vision. It’s exciting to watch the pieces come together, and we look forward to supplying and growing the MDRN Tree brand and continuing to develop a model that will give our cultivation business wider distribution at potentially higher margins. Each day we continue to make history,” Yu said, further discussing the company’s positioning in a top market. “California is the world’s fifth-largest economy. We are number one in the nation for many things, like starting new businesses. We are number one in manufacturing, agriculture, entertainment, tourism, technology and college graduates. And we are also number one in the world for legal cannabis. Our state has the largest legal cannabis market in the world.”

To view the full article, visit https://cnw.fm/FHuCQ

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Study Results Expected to Demonstrate DehydraTECH-CBD’s Effectiveness Against Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its human clinical study HYPER-H21-3 is expected to complete all dosing and sample collection this week. The study, undertaken to examine the effects of DehydraTECH-CBD upon acute pulmonary hypertension, used a blinded design with administration of a single 300mg dose of a specific DehydraTECH 2.0 CBD formulation compared to placebo in a target group of sixteen enrolled volunteers. Subject to pending analysis of samples collected from the study, blood pressure results are expected to be reported soon. Exposure to acute reductions in oxygen tension (i.e., hypoxia) causes rapid hypoxic pulmonary vasoconstriction (“HPV”) and pulmonary arterial pressure increases as a consequence of this HPV response. If the increase in pressure becomes too high, an excess of fluid in the lungs can occur that causes difficulty with breathing. The extent to which CBD may act as a novel treatment for HPV and potentially as an alternative treatment for pulmonary hypertension is unknown. Therefore, the primary objective of the study is to evaluate the effect of DehydraTECH-CBD on pulmonary vascular function in normotensive individuals exposed to hypoxia. Results from HYPER-H21-3 are expected to add to Lexaria’s growing body of evidence for the effectiveness of DehydraTECH-CBD against hypertension, and findings will be submitted to regulators such as the FDA as Lexaria pursues its planned investigational new drug research program.

To view the full press release, visit https://cnw.fm/JzGB4

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Review Webinar

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will provide an overview on the company’s performance at a year-end review; the online event is scheduled for today, Dec. 14, 2021, at 4:30 p.m. ET. Flora Growth CEO Luis Merchan will host the webinar, which will include an update on the company’s 2021 operational performance as well as commentary on its 2022 revenue guidance of $35 to $45 million; the event will also include a Q&A session. Anyone interested in attending is invited to participate. Questions can be submitted in advance for the question-and-answer portion of the webinar.

To view the webinar, visit https://cnw.fm/jtrmh

To view the full press release, visit https://cnw.fm/Dx8Cb

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — California Starts Process to Standardize Marijuana Testing

Regulators in the state of California have begun to standardize marijuana testing as mandated by a new law in the state. The objective of this is to eliminate inconsistencies observed in operational cannabis laboratories in the state.

Advocates believe that the law will improve reliability and quality as well as discourage laboratory shopping and other practices that produce inauthentic test results. Officials involved in the industry claim that some cannabis businesses look for labs that will produce the results they’d like to see with regard to contaminants and THC potency.

Critics also assert that the absence of standards is also affecting the marijuana testing industry, as it undermines consumer confidence in cannabis products and makes it harder for some laboratories to operate. Christina Dempsey, spokeswoman for the state’s Department of Cannabis Control, stated that the initiative would bring additional accountability and consistency among licensed marijuana testing labs.

She explained that with standardized tests, labs could more easily identify and rectify issues, noting that standardization would also ensure integrity. The department has designated a pair of laboratories managed by the state to create procedures that will be used as a blueprint for every cannabis testing laboratory in the state.

The law will also ensure that testing labs are more transparent about their operations and provide more accurate results. This initiative makes California the latest state to have standardized cannabis testing methods. Other states in this category include New York and New Jersey.

The new law, dubbed Senate Bill 544, was signed by California Governor Gavin Newsom in October. The law requires that the state’s  Department of Cannabis Control establish criteria and guidelines for the testing of marijuana compounds, residual solvents, microbiological contaminants and pesticides.

The bill states that by January 2023, said department should have established standardized operating procedures and testing methods for cannabinoids that all laboratories will be using. Every testing laboratory in the state will be required to implement the department’s operating procedures, which advocates believe will cut down on laboratory shopping.

Currently, state law mandates that distributors act as liaisons between growers and cannabis dispensaries. Distributors are also required to hold inventory until tests are conducted as well as arrange for testing.

The state legalized the growing, sale and use of recreational marijuana in 2016. Jeffrey Raber, an organic chemist who launched one of the first marijuana testing laboratories in the state more than 10 years ago, believes that developing standardized cross validation and methodologies will eliminate bad actors in the market.

Once the uniform testing standards are implemented, the entire sector, including companies such as American Cannabis Partners, is bound to benefit as the industry will climb a notch higher.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.